Asset Publisher

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis

 

Karl Carlström, photo Stefan Zimmerman

 

Karl Carlström (first author), Faiez al Nimer and Fredrik Piehl, from CMM (Fredrik Piehl Team), together with coauthors, published a study in which they found a new substance which could potentially be more specific for treating multiple sclerosis (MS) than currently used drugs. Dimethyl fumarate (DMF)/tecfidera is today a leading first-line treatment for relapsing-remitting MS worldwide. The researchers performed an experimental study using animal models, in which they compared DMF to other substances, measuring the protective effect on oligodendrocytes, the cells that are being injured and destroyed in MS.

More details can be found at ki.se (in Swedish). The paper was published in Neurotherapeutics.

NEWS

New Molecular Insights into Disease Exacerbation in Multiple Sclerosis

New Molecular Insights into Disease Exacerbation in Multiple Sclerosis Importance of the Atg7 gene for the recovery from inflammation in the central nervous system Multiple...

Grant from Forte to Xia Jiang

Grant from Forte to Xia Jiang Xia Jiang, Assistant Professor in Ingrid Kockum’s Group at CMM, is one of the 11 researchers from Karolinska Institutet who received research grants as a part...

Improved Patient Classification in Chronic Lymphocytic Leukemia

Improved Patient Classification in Chronic Lymphocytic Leukemia CMM Group Leader Professor Richard Rosenquist Brandell, is one of the main coauthors of a large study recently published in ...

Finding Molecular Links between Stress and Depression

Finding Molecular Links between Stress and Depression Vasco Sousa, researcher in Per Svenningson’s Group at CMM, is the first author of a study with the title “P11 deficiency increases...

Nanna Svartz Scholarship for Outstanding Research in Rheumatology 2020

Nanna Svartz Scholarship for Outstanding Research in Rheumatology 2020 The Nanna Svartz scholarship for outstanding research in rheumatology 2020 is awarded to Marie Wahren-Herlenius,...

Susanna Brauner Awarded the Swedish Society of Medicine's Translational Research Prize

Susanna Brauner Awarded the Swedish Society of Medicine's Translational Research Prize Susanna Brauner , Assistant professor and CMM researcher (Fredrik Piehl’s Team) has received the...

Ning Xu Landén 2020 Year’s Winner of the LEO Foundation Award

Ning Xu Landén 2020 Year’s Winner of the LEO Foundation Award Associate Professor Ning Xu Landén, Group Leader at CMM is the winner of this year’s LEO Foundation Award in Region EMEA...

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system Photo: Hans Ericksson, SSMF Nils Landegren , Researcher at CMM, has been awarded...

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife Photo: Mattias Bronge, Karolinska Institutet A validation project of new SARS-CoV-2 antibody tests,...

Grant to Qiaolin Deng for the single-cell technology core at CMM

Grant to Qiaolin Deng for the single-cell technology core at CMM Qiaolin Deng, private photo We congratulate Associate Professor and CMM Team Leader Qiaolin Deng who received a SFO...